Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European stocks end flat as defensive gains offset auto slide

Mon, 18th Nov 2019 17:51

* Spanish bourse BME hits 4-year high

* Volkswagen cuts sales and profit forecast

* Defensive shares gain amid trade uncertainty

* FTSE 100 outperforms
(Updates to close, changes quotes, adds news items)

By Medha Singh and Agamoni Ghosh

Nov 18 (Reuters) - European stocks ended flat on Monday as a
spurt of defensive buying over uncertainty surrounding
U.S.-China trade talks helped temper losses in the auto sector.

The pan-European STOXX 600 index finished little
changed, after having spent most of the session in negative
territory.

The European automobiles and parts sector dropped
2.1%, its steepest fall in about four weeks, with Germany's
Volkswagen leading declines after it slashed its
operating profit and sales growth outlook due to slowdown in the
auto sector.

"Volkswagen is seen as a barometer for the industry and any
kind of warning from them can be concerning," said David Madden,
market analyst at CMC Markets in London.

This comes after a string of automakers including fellow
German peer Daimler and part supplier Continental
warned of tough times for an industry facing higher
investments into cleaner and self-driving technologies.

Also weighing on the sector was an over 3% decline in shares
of France's Peugeot after Deutsche Bank downgraded the
stock to "hold."

Conflicting trade headlines kept investors cautious with
sectors traditionally considered defensive, such as real estate
, utilities and healthcare leading
gains.

News on the trade war was conflicting. Sentiment in the
afternoon took a hit after a CNBC report said the mood in
Beijing about a deal was pessimistic due to U.S. President
Donald Trump's reluctance to roll back tariffs.

However, late in the session, the Trump administration
issued a new 90-day extension allowing U.S. companies to
continue doing business with China's Huawei Technologies Co Ltd
.

"The comments from both countries are getting hard to follow
now, they change their tone every other day," said Hubert de
Barochez, economist at Capital Economics, London.

Gains in defensive stocks including AstraZeneca,
GlaxoSmithKline and British American Tobacco
helped London's blue-chip FTSE 100 rise 0.1%, to
outperform the broader market.

Optimism surrounding a Sino-U.S. trade talks and better than
expected corporate results had helped STOXX 600 hit 4 year high
last week.

In a bright spot, shares of Bolsas y Mercados Espanoles
(BME) rocketed 38% as stock market operator Euronext
and Switzerland's SIX sparked a bidding war for the
Spanish firm, with both trying to snap up one of Europe's last
standalone stock exchanges.

Qiagen jumped 8% after the German genetic testing
company said it would start talks with several potential
suitors.
(Reporting by Medha Singh and Agamoni Ghosh in Bengaluru;
Editing by Shounak Dasgupta, Patrick Graham and Toby Chopra)

More News
3 Jun 2024 17:19

Pharma, energy stocks drag London's FTSE 100; ECB rate cut hopes cap losses

FTSE 100 down 0.2%, FTSE 250 up 0.8%

*

Read more
3 Jun 2024 17:00

LONDON MARKET CLOSE: FTSE 100 down amid shaky start in New York

(Alliance News) - The FTSE 100 in London closed lower on Monday, marking a mixed start to June, with GSK firmly at the bottom of the index.

Read more
3 Jun 2024 14:01

GSK immunotherapy bowel cancer drug works for 100% of patients

(Alliance News) - An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Read more
3 Jun 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 up, while Labour commits to defence

(Alliance News) - Stock prices in London were up at midday, after data from S&P Global signalled a return to growth for the UK manufacturing sector.

Read more
3 Jun 2024 09:08

TOP NEWS: GSK vows to appeal adverse Delaware court ruling on Zantac

(Alliance News) - GSK PLC on Monday said it will appeal a US court ruling that it should face jury trials relating to cases concerning the heartburn drug, Zantac.

Read more
3 Jun 2024 08:37

LONDON MARKET OPEN: Stocks up amid slew of manufacturing PMIs

(Alliance News) - Stock prices in London opened higher on Monday, ahead of local purchasing managers index data, and comparative prints from several other major global economies.

Read more
3 Jun 2024 08:00

LONDON BRIEFING: FTSE 100 seen up; GSK defends ranitidine cancer claim

(Alliance News) - Stocks in London are set to open higher on Monday, ahead of a data-heavy week, kicked off by a slew of manufacturing purchasing managers' index readings.

Read more
3 Jun 2024 07:30

GSK to appeal Delaware ruling on jury trials in Zantac cancer cases

(Sharecast News) - GSK shares were down almost 10% on Monday after a US court ruled that jury trials could hear expert witnesses in 70,000 cases brought by cancer sufferers claiming its Zantac heartburn drug caused their condition.

Read more
1 Jun 2024 21:35

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
1 Jun 2024 21:07

Delaware judge lets more than 70,000 Zantac lawsuits go forward

June 1 (Reuters) - A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that the drug may cause cancer.

Read more
31 May 2024 17:45

US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label

May 31 (Reuters) - The U.S. Food and Drug Administration approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
31 May 2024 16:01

US FDA approves Moderna's RSV vaccine, its second marketed product

May 31 (Reuters) - The U.S. Food and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed new revenue from a second product.

Read more
30 May 2024 20:56

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 30 (Reuters) - A third U.S. dairy worker tested positive for bird flu after exposure to infected cows, and was the first to suffer respiratory symptoms, U.S. officials said on Thursday in the latest expansion of the outbreak. Bird flu has been found in dairy cattle in nine states. This second case in a Michigan dairy worker was found through increased testing of people and cows in the state following the April 1 identification of a case in a Texas farm worker. Here's what you need to know about the outbreak.

WHY IS H5N1 OR BIRD FLU A CONCERN?

Read more
30 May 2024 09:23

LONDON BROKER RATINGS: Jefferies and UBS cut Anglo American

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

Read more
30 May 2024 07:40

LONDON BRIEFING: Dr Martens cuts payout as profit plummets

(Alliance News) - Stocks in London are called to open lower on Thursday, with investors nervous ahead of Friday's US inflation print.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.